Skip to content

Ulrik Mouritzen

CEO

OSH lists public professional information only. To request removal, use this form; requests are handled within 24 hours.

Sources

  1. 1.Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases — EU-Startups, Oct 2, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026